What can we learn from the implementation of a novel point-of-care Antigen-Based SARS-CoV-2 Rapid Diagnostic Test to Screen Incoming Patients in a large University Hospital? (COVID-19)

What can we learn from the implementation of a novel point-of-care Antigen-Based SARS-CoV-2 Rapid Diagnostic Test to Screen Incoming Patients in a large University Hospital? (COVID-19) - ANCOR

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023584

Enrollment

Registered

2020-11-17

Start date

2020-11-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

Group 1: Work Package 1: Unstructured Observations of the testing situation

In-depth Interviews (IDIs) with members of the COVID-19 Task-Force at UKHD and trainers for AG-RDTs. Work Package 2: Structured observations of the testing situation in four purposefully selected depa

IDIs with department heads, providers performing AG-RDTs with patients or working with patients who were tested with AG-RDTs, and patients tested with AG-RDTs. Work Package 3: IDIs at late-implementin

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 18 years or older; capable to give informed consent, having signed informed consent. For heads of departments: Head of a department at UKHD currently employing a RDT-based COVID-19 testing strategy following the task-forces recommendation. For practitioners: Medical practitioner (e.g. nurses, medical doctors) responsible for performing RDTs with patients at a clinic within UKHD. For Patients: Patient admitted for elective care, emergency care, or outpatient treatment to a clinic within UKHD and having been tested for COVID-19 using a RDT. Heads of non/late-implementing department: Head of a department at UKHD currently not employing a RDT-based COVID-19 testing strategy following the task-forces recommendation. Task-Force Members: Member of the COVID-19 task force at UKHD involved in preparing the recommendation with regards to COVID-19 RDTs Trainers: Individual responsible for capacity building for and implementation of RDT testing strategies at UKHD.

Exclusion criteria

Exclusion criteria: Refusing or withdrawing informed consent; Incapacitated persons (mentally challenged; physical disability – i.e. hearing and speech impaired; totally blind)

Design outcomes

Primary

Measure	Time frame
Analysis of the implementation of the AG-RDTs at UKHD (fidelity, adoption, adaptation), based on the interviews, observations, and diagnostic yield data described above.	—

Secondary

Measure	Time frame
Recommendations for future implementation of AG-RDT-based testing strategies in high-risk settings, based on the collected data (Interviews, observations, data on diagnostic yield).	—

Countries

Germany

Contacts

Public ContactClaudia Denkinger

Universitätsklinikum Heidelberg

claudia.denkinger@uni-heidelberg.de+49 (0)6221 56-36637

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026